Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sleep and Cognitive Function in Multiple Sclerosis.
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
A case of posterior reversible encephalopathy syndrome associated with gilenya(®) (fingolimod) treatment for multiple sclerosis.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Mast cell inflammasome activity in the meninges regulates EAE disease severity.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
Differing trends in the incidence of vascular comorbidity in MS and the general population.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
[The overall assessment of the quality of the physical health of patients with multiple sclerosis after the application of physical therapy. Part 1].

Pages